FDA Advisers Recommend , Anti-Opioid Overdose Drug for OTC Use.<br />'The Hill' reports that on Feb. 15, <br />an FDA panel voted 19-0 in favor of Naloxone <br />being made available over the counter.<br />'The Hill' reports that on Feb. 15, <br />an FDA panel voted 19-0 in favor of Naloxone <br />being made available over the counter.<br />Currently, the anti-opioid overdose drug <br />is only available with a prescription.<br />Sold under the brand name Narcan, <br />the drug is widely considered to be the <br />best treatment for opioid overdoses. .<br />It was first approved in 2015 to treat opioid overdoses in people of all ages, even newborns. .<br />The advisory panel agrees that there is little to no risk in making the drug available over the counter.<br />The advisory panel agrees that there is little to no risk in making the drug available over the counter.<br />There’s no reason to keep this <br />as a prescription, let’s get it <br />out there and save some lives, Elizabeth Coykendall, temporary panel member <br />and a paramedic in North Carolina, via 'The Hill'.<br />The cost of the drug has yet to be determined.<br />'The Hill' reports that harm reduction advocates fear it may be too expensive for groups that give it to those who need it most.<br />The FDA is expected to make a decision <br />about whether Naloxone should be made available over the counter by March 29.<br />The FDA is expected to make a decision <br />about whether Naloxone should be made available over the counter by March 29
